A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for the cognitive impairment of schizophrenia

被引：2
|
作者：
Tugal, O [1 ]
Yazici, KM [1 ]
机构：
[1] Hacettepe Univ, Fac Med, Dept Psychiat, TR-06100 Ankara, Turkey
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)91990-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [41] DOUBLE-BLIND PLACEBO-CONTROLLED CROSS-OVER TRIAL OF CISAPRIDE IN POSTGASTRECTOMY PATIENTS WITH DUODENOGASTRIC REFLUX (DGR)
    VAEZI, M
    SEARS, R
    RICHTER, J
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : A249 - A249
  • [42] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington's disease
    Lopez-Sendon Moreno, Jose Luis
    Garcia Caldentey, Juan
    Trigo Cubillo, Patricia
    Ruiz Romero, Carolina
    Garcia Ribas, Guillermo
    Alonso Arias, M. A. Alonso
    Jesus Garcia de Yebenes, Maria
    Maria Tolon, Rosa
    Galve-Roperh, Ismael
    Sagredo, Onintza
    Valdeolivas, Sara
    Resel, Eva
    Ortega-Gutierrez, Silvia
    Laura Garcia-Bermejo, Maria
    Fernandez Ruiz, Javier
    Guzman, Manuel
    de Yebenes Prous, Justo Garcia
    [J]. JOURNAL OF NEUROLOGY, 2016, 263 (07) : 1390 - 1400
  • [43] Hyoscine for clozapine-induced hypersalivation: a double-blind, randomized, placebo-controlled cross-over trial
    Segev, Aviv
    Evans, Anthony
    Hodsoll, John
    Whiskey, Eromona
    Sheriff, Rebecca S.
    Shergill, Sukhi
    MacCabe, James H.
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2019, 34 (02) : 101 - 107
  • [44] A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
    Otmar Bayer
    Tatiana Brémová
    Michael Strupp
    Katharina Hüfner
    [J]. Journal of Neurology, 2018, 265 : 291 - 298
  • [45] DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSS-OVER TRIAL OF PROGABIDE AS ADD-ON THERAPY IN EPILEPTIC PATIENTS
    DEPASQUET, EG
    SCARAMELLI, A
    DECACERES, MP
    LHERITIER, C
    FELDMAN, S
    SANTANA, R
    AGUILAR, J
    MUSCH, B
    MORSELLI, PL
    [J]. EPILEPSIA, 1991, 32 (01) : 133 - 139
  • [46] Sinonasal inhalation of dornase alfa in CF: A double-blind placebo-controlled cross-over pilot trial
    Mainz, Jochen G.
    Schiller, Isabella
    Ritschel, Christiane
    Mentzel, Hans-Joachim
    Riethmueller, Joachim
    Koitschev, Assen
    Schneider, Gerlind
    Beck, James F.
    Wiedemann, Baerbel
    [J]. AURIS NASUS LARYNX, 2011, 38 (02) : 220 - 227
  • [47] A double-blind, cross-over comparison of the effects of amantadine or placebo-on visuomotor and cognitive function in medicated schizophrenia patients
    Silver, H
    Goodman, C
    Isakov, V
    Knoll, G
    Modai, I
    [J]. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (06) : 319 - 326
  • [48] A double-blind, randomized, cross-over, placebo-controlled, pilot trial with Sativex in Huntington’s disease
    Jose Luis López-Sendón Moreno
    Juan García Caldentey
    Patricia Trigo Cubillo
    Carolina Ruiz Romero
    Guillermo García Ribas
    M. A. Alonso Alonso Arias
    María Jesús García de Yébenes
    Rosa María Tolón
    Ismael Galve-Roperh
    Onintza Sagredo
    Sara Valdeolivas
    Eva Resel
    Silvia Ortega-Gutierrez
    María Laura García-Bermejo
    Javier Fernández Ruiz
    Manuel Guzmán
    Justo García de Yébenes Prous
    [J]. Journal of Neurology, 2016, 263 : 1390 - 1400
  • [49] A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine
    Bayer, Otmar
    Bremova, Tatiana
    Strupp, Michael
    Huefner, Katharina
    [J]. JOURNAL OF NEUROLOGY, 2018, 265 (02) : 291 - 298
  • [50] Adjunctive tropisetron therapy for cognitive deficits in patients with schizophrenia: A 8-week, double-blind, placebo-controlled trial
    Shiina, A.
    Shirayama, Y.
    Niitsu, T.
    Hashimoto, T.
    Iyo, M.
    Hashimoto, K.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 241 - 241
12345